NANDRORAPID (Nandrolone Phenylpropionate) is an injectable steroid, this drug contains Nandrolone Phenylpropionate and is made by Alpha Pharma.
Nandrolona F is chemically related to the male hormone. Compared to testosterone, it has an enhanced anabolic and a reduced androgenic activity. This has been demonstrated in animal bioassays and explained by receptor binding studies. The low androgenicity of nandrolone is confirmed in clinical use. In the human, Nandrolona F has been shown to positively influence calcium metabolism. And to increase bone mass in osteoporosis.
In women with disseminated mammary carcinoma. Nandrolona F has been reported to produce objective regressions for many months. Furthermore, Nandrolone has a nitrogen-saving action. This effect on protein metabolism has been established by metabolic studies. And also is utilized therapeutically in conditions where a protein deficiency exists. Such as during chronic debilitating diseases and after major surgery.
Nandrolone Phenylpropionate NANDRORAPID
In these conditions, Nandrolone Phenylpropionate serves as a supportive adjunct to specific therapies. And dietary measures as well as parenteral nutrition. Hence it’s due to its faster acting nature Nandrolone Phenylpropionate. It is preffered in situations where a faster clinical response is required. Required over its chemical variant Nandrolone decanoate.
It’s a progestin, like any Nandrolone derivative. And is made by removing the carbon atom at the 19th position of the Steran Nucleus of testosterone. However, although it’s a progestin, Nandrolone (regardless of ester). Doesn’t produce much of what we could properly call estrogenic side effects. Any side effects from Nandrolone Phenylpropionate would therefore more properly be termed progestenic in nature. As it only converts to estrogen at roughly 20% the rate of testosterone.
Regardless of ester, and water retention not withstanding. We find that all of the characteristics of found in one type of Nandrolone are found in any other. Nandrolone, probably owing to its progestenic nature. Has the ability to improve collagen synthesis as well.
Clearly this would be a huge benefit to athletes with connective tissue problems or other joint issues, although drug-tested athletes need to avoid Nandrolona F because of their detectability in urine for a year to eighteen months after administration. Also, since it is a progestin (with slight estrogenic ability), it probably has some very beneficial effects on the immune-mediated anti-inflammatory process, thereby soothing joints as well as helping to heal them.
Nandrolona F is used to treat anemia by stimulating red blood cell production, and an increase in RBC count can improve endurance during exercise via better lactic acid clearing and oxygen delivery. The blood is also better enabled to carry nutrients to muscle tissue to aid in repair, administration also increases the rate of muscle glycogen repletion after exercise helping the athlete dramatically improve recovery after strenuous physical exercise.
Athletes who require a high level of endurance in their chosen sport can benefit from the use of Nandrolona F. A favorite with bodybuilders who suffer with sore joints, Nandrolona F can also improve collagen synthesis, which may improve joint function and alleviate joint pains.
Although many nandrolone lovers claim that it is one of the safest Anabolic Steroids, if not the safest. It does have side effects that can be bothersome in hypersensitive individuals, such as acne, excitation, insomnia, nausea, diarrhea and bladder irritability. More serious side effects include testicular atrophy, impotence and gynecomastia. Nandrolona F use has been shown to be safe and easy on the lipid profile, often improving HDL Cholesterol Impotence can be offset by stacking the nandrolone with a higher testosterone.
Nandrolona F also causes the “shut down” of natural testosterone production. Thus an exogenous source must be provided, the increased prolactin levels from the use of a progestinic steroid contribute to HPTA shut down and testicular atrophy which can be treated with a combination HCG and Bromocriptine. Besides using Bromcriptine to lower prolactin levels, the anti-estrogens fulvestrant or Letrozole on be taken to down regulate the progesterone and estrogen receptor.